YU65899A - Stabilizovani karbapenem intermedijari i sintetska upotreba - Google Patents

Stabilizovani karbapenem intermedijari i sintetska upotreba

Info

Publication number
YU65899A
YU65899A YU65899A YU65899A YU65899A YU 65899 A YU65899 A YU 65899A YU 65899 A YU65899 A YU 65899A YU 65899 A YU65899 A YU 65899A YU 65899 A YU65899 A YU 65899A
Authority
YU
Yugoslavia
Prior art keywords
synthetic use
formula
stabilized carbapenem
carbapenem intermediates
stabilized
Prior art date
Application number
YU65899A
Other languages
English (en)
Inventor
John M. Williams
Karel M.J. Brands
Renato T. Skerlj
Ulf H. Dolling
Ronald B. Jobson
Original Assignee
Merck & Co. Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9719383.3A external-priority patent/GB9719383D0/en
Application filed by Merck & Co. Inc. filed Critical Merck & Co. Inc.
Publication of YU65899A publication Critical patent/YU65899A/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Opisano je stabilizovano karbapenem intermedijarno jedinjenje predstavljeno formulom (1) ili njegova so, gde P predstavlja zaštitnu grupu za karboksil i X predstavlja grupu koja uravnotežuje naelektrisanje. Pored toga, opisan je postupak za sintetizovanje jedinjenja predstavljenog formulom (2) gde je X+ grupa koja uravnotežuje naelektrisanje, koji obuhvata: oslobadjanje od zaštite jedinjenja formule (1), pri čemu se dobija jedinjenje (2).
YU65899A 1997-06-16 1998-06-12 Stabilizovani karbapenem intermedijari i sintetska upotreba YU65899A (sh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4964097P 1997-06-16 1997-06-16
GBGB9719383.3A GB9719383D0 (en) 1997-09-11 1997-09-11 Stabilized carbapenem intermediates and improved process for carbapenem synthesis

Publications (1)

Publication Number Publication Date
YU65899A true YU65899A (sh) 2001-05-28

Family

ID=26312229

Family Applications (1)

Application Number Title Priority Date Filing Date
YU65899A YU65899A (sh) 1997-06-16 1998-06-12 Stabilizovani karbapenem intermedijari i sintetska upotreba

Country Status (20)

Country Link
EP (1) EP0991651B1 (sh)
JP (1) JP3245427B2 (sh)
KR (1) KR100364339B1 (sh)
CN (1) CN1105719C (sh)
AT (1) ATE254127T1 (sh)
AU (1) AU726882B2 (sh)
BR (1) BR9810135A (sh)
CA (1) CA2293835C (sh)
DE (1) DE69819727T2 (sh)
DK (1) DK0991651T3 (sh)
EA (1) EA001926B1 (sh)
ES (1) ES2210773T3 (sh)
HU (1) HUP0004243A3 (sh)
NZ (1) NZ500955A (sh)
PL (1) PL337016A1 (sh)
PT (1) PT991651E (sh)
SK (1) SK179799A3 (sh)
UA (1) UA58469C2 (sh)
WO (1) WO1998057973A1 (sh)
YU (1) YU65899A (sh)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6548492B1 (en) * 1999-10-29 2003-04-15 Merck & Co., Inc. Process for formulation of carbapenem antibiotic compositions
EP1244444B1 (en) * 1999-10-29 2004-12-29 Merck & Co., Inc. Process for formulation of carbapenem antibiotic compositions
EP1426376A4 (en) * 2001-08-13 2004-12-22 Eisai Co Ltd PROCESS FOR THE PREPARATION OF CARBAPENEM-BASED ANTIBIOTICS
EP1686129A1 (de) * 2004-08-18 2006-08-02 Sandoz AG Carbapenem-Verbindungen, ihre Herstellung und Verwendung in Synthese von Carbapenemen
CN100582106C (zh) * 2006-01-27 2010-01-20 上海医药工业研究院 一种吡咯烷硫基碳青霉烯衍生物的制备方法及其中间体
CN101328179B (zh) * 2007-06-15 2011-01-12 山东轩竹医药科技有限公司 含有氧代氮杂环的巯基吡咯烷培南衍生物
CN101367804B (zh) * 2007-06-26 2010-12-15 山东轩竹医药科技有限公司 含有金刚烷的培南衍生物
CN101362760B (zh) * 2007-08-07 2010-12-15 山东轩竹医药科技有限公司 1β-甲基碳代青霉烯化合物
EP2505190A1 (en) * 2008-06-11 2012-10-03 Ranbaxy Laboratories Limited Polymorphic forms of ertapenem monosodium salt and process for it's preparation
US20130079322A1 (en) * 2010-05-21 2013-03-28 Xuanzhu Pharama Co., Ltd. Crystalline of carbapenem derivative or its hydrate, preparation methods and uses thereof
KR20150065176A (ko) 2012-10-12 2015-06-12 산도즈 아게 에르타페넴 중간체의 제조법
WO2014085471A1 (en) * 2012-11-28 2014-06-05 Prognosdx Health, Inc. Acid-activated compositions for the treatment of cancers, methods of their use and methods of their preparation
CN103537192A (zh) * 2013-10-25 2014-01-29 上海珺领生化科技有限公司 一种提纯、浓缩厄他培南水溶液的膜集成装置

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9202298D0 (en) * 1992-02-04 1992-03-18 Ici Plc Antibiotic compounds
HRP970281B1 (en) * 1996-05-28 2002-04-30 Merck & Co Inc Carbapenem antibiotic, composition and method of preparation

Also Published As

Publication number Publication date
EP0991651A4 (en) 2001-06-13
NZ500955A (en) 2001-06-29
BR9810135A (pt) 2000-08-08
CN1259949A (zh) 2000-07-12
EA001926B1 (ru) 2001-10-22
AU726882B2 (en) 2000-11-23
CN1105719C (zh) 2003-04-16
DE69819727T2 (de) 2004-09-23
ATE254127T1 (de) 2003-11-15
HUP0004243A3 (en) 2001-12-28
PT991651E (pt) 2004-03-31
SK179799A3 (en) 2000-09-12
JP2000511206A (ja) 2000-08-29
KR100364339B1 (ko) 2002-12-18
DE69819727D1 (de) 2003-12-18
DK0991651T3 (da) 2004-03-08
CA2293835C (en) 2003-09-16
JP3245427B2 (ja) 2002-01-15
PL337016A1 (en) 2000-07-31
EP0991651B1 (en) 2003-11-12
EP0991651A1 (en) 2000-04-12
KR20010013774A (ko) 2001-02-26
ES2210773T3 (es) 2004-07-01
HUP0004243A2 (en) 2001-03-28
UA58469C2 (uk) 2003-08-15
CA2293835A1 (en) 1998-12-23
EA200000030A1 (ru) 2000-06-26
WO1998057973A1 (en) 1998-12-23
AU8142998A (en) 1999-01-04

Similar Documents

Publication Publication Date Title
YU65899A (sh) Stabilizovani karbapenem intermedijari i sintetska upotreba
TW349098B (en) Naphthalene derivatives, process for the preparation thereof, and intermediates therefor
YU34896A (sh) Supstituisani n-(indol-2-karbonil)-glicinamidi, njihovi intermedijeri i farmaceutske kompozicije
YU41198A (sh) Derivati pirolopirolona kao inhibitori neutrofilne elastaze
MY108967A (en) Triazolopyridazine compounds, their production and use
ZA951227B (en) Camptothecin derivatives and process for their preparation
RS50494B (sr) Poboljšani postupak za sintezu karbapenema
HUP0003484A2 (hu) Pirrolidin-3-karbonsav-származékok és alkalmazásuk endotelin antagonistaként
FI940414A (fi) Kinoliini- tai kinatsoliinijohdannaiset, niiden valmistus ja käyttö
YU62991A (sh) Karbapenemska jedinjenja
CA2226406A1 (en) Novel pyridone carboxylic acid derivatives
ATE271043T1 (de) Verfahren zur herstellung von 2-chlor-5- chloromethyl-thiazol
YU183090A (sh) Novi n-acildipeptidi, postopki za njihovo pripravo in farmacevtski pripravki, kojih vsebujejo
Bose et al. Non-hazardous synthesis of isocephosphorin intermediates via α-vinylamino-β-lactams
MY110751A (en) Positive inotropic and lusitropic pyrroloquinolinone derivatives
ES483676A1 (es) Un procedimiento para preparar compuestos de acido 3-cefem- 4-carboxilico disustituidos en las posiciones 3 y 7
HRP20000027B1 (en) Process for the preparation of alkoxyfuranoneamine derivatives, compounds obtained by this process, and the use of these compounds
RS49710B (sr) Postupak sinteze hloropurinskih intermedijara
EA199800289A1 (ru) Производные пептидов
IE820238L (en) Carbapenem derivatives
YU74501A (sh) Sinteza 3-amino-3-aril propionata
YU48445B (sh) Postupak za dobijanje novih 4-hidroksikumarin i 1 3-indandion derivata
ATE256198T1 (de) Enzimatische synthese von peptidomimetika
GB2013689A (en) Enkephalin analogues
GB1434645A (en) Tetrazole coumarin derivatives